Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 841497, 7 pages
http://dx.doi.org/10.1155/2014/841497
Research Article

Risks of Decreased Renal Function and Increased Albuminuria for Glycemic Status and Metabolic Syndrome Components: Taichung Community Health Study

1Department of Family Medicine, China Medical University Hospital, Taichung 40402, Taiwan
2School of Medicine, College of Medicine, China Medical University, Taichung 40402, Taiwan
3Department of Medical Research, China Medical University Hospital, Taichung 40402, Taiwan
4Medical College, Department of Psychiatry, Medical College, National Cheng Kung University, Tainan 70101, Taiwan
5Bristol-Myers Squibb Ltd, Global Development & Medical Affair, Taipei 10586, Taiwan
6Division of Endocrinology and Metabolism, Department of Medicine, China Medical University Hospital, Taichung 40402, Taiwan
7Graduate Institute of Biostatistics, College of Management, China Medical University, Taichung 40402, Taiwan
8Department of Healthcare Administration, College of Health Science, Asia University, Taichung 41354, Taiwan

Received 10 January 2014; Revised 16 April 2014; Accepted 21 April 2014; Published 12 May 2014

Academic Editor: Abel Romero-Corral

Copyright © 2014 Cheng-Chieh Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. US Renal Data System, “USRDS, 2004 annual data report,” American Journal of Kidney Diseases, vol. 45, supplement 1, no. 2, pp. S8–S80, 2005. View at Publisher · View at Google Scholar
  2. H.-W. Kuo, S.-S. Tsai, M.-M. Tiao, and C.-Y. Yang, “Epidemiological features of CKD in Taiwan,” American Journal of Kidney Diseases, vol. 49, no. 1, pp. 46–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. Ministry of Health and Welfare, “ROC: Annual Statistics Report,” 1994–2012, http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=1601.
  4. H.-Y. Chang, W.-T. Yeh, Y.-H. Chang, K.-S. Tsai, and W.-H. Pan, “Prevalence of dyslipidemia and mean blood lipid values in Taiwan: results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993–1996),” Chinese Journal of Physiology, vol. 45, no. 4, pp. 187–197, 2002. View at Google Scholar · View at Scopus
  5. W. H. Pan, H. J. Wu, C. J. Yeh et al., “Diet and health trends in Taiwan: comparison of two nutrition and health surveys from 1993–1996 and 2005–2008,” Asia Pacific Journal of Clinical Nutrition, vol. 20, no. 2, pp. 238–250, 2011. View at Google Scholar
  6. Y. Li, L. Zhao, Y. Chen et al., “Association between metabolic syndrome and chronic kidney disease in perimenopausal women,” International Journal of Environmental Research and Public Health, vol. 10, no. 9, pp. 3987–3997, 2013. View at Publisher · View at Google Scholar
  7. J. A. Cho, S. J. Lee, E. A. Reid, and S. H. Jee, “Metabolic syndrome component combinations and chronic kidney disease: the severance cohort study,” Maturitas, vol. 75, no. 1, pp. 74–80, 2013. View at Publisher · View at Google Scholar
  8. S. D. Navaneethan, J. D. Schold, J. P. Kirwan et al., “Metabolic syndrome, ESRD, and death in CKD,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 6, pp. 945–952, 2013. View at Publisher · View at Google Scholar
  9. R. Kelishadi, A. Gheissari, N. Bazookar, M. E. Motlagh, M. Taslimi, and G. Ardalan, “Kidney function in obese adolescents with or without metabolic syndrome in a nationally-representative sample of pediatric population: first report from the Middle East and North Africa: the CASPIAN-III Study: a Case-Control Study,” Journal of Research in Medical Sciences, vol. 18, no. 3, pp. 178–183, 2013. View at Google Scholar
  10. B. C. Astor, S. I. Hallan, E. R. Miller 3rd, E. Yeung, and J. Coresh, “Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population,” American Journal of Epidemiology, vol. 167, no. 10, pp. 1226–1234, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Chen, P. Muntner, L. L. Hamm et al., “The metabolic syndrome and chronic kidney disease in U.S. adults,” Annals of Internal Medicine, vol. 140, no. 3, pp. 167–174, 2004. View at Google Scholar · View at Scopus
  12. C.-C. Lin, C.-S. Liu, T.-C. Li, C.-C. Chen, C.-I. Li, and W.-Y. Lin, “Microalbuminuria and the metabolic syndrome and its components in the Chinese population,” European Journal of Clinical Investigation, vol. 37, no. 10, pp. 783–790, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. C.-C. Lin, C.-S. Liu, M.-M. Lai et al., “Metabolic syndrome in a Taiwanese metropolitan adult population,” BMC Public Health, vol. 7, article 239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. W.-Y. Lin, C.-S. Liu, T.-C. Li et al., “In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study),” Annals of the Rheumatic Diseases, vol. 67, no. 3, pp. 432–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-S. Liu, F. X. Pi-Sunyer, C.-I. Li et al., “Albuminuria is strongly associated with arterial stiffness, especially in diabetic or hypertensive subjects-A population-based study (Taichung Community Health Study, TCHS),” Atherosclerosis, vol. 211, no. 1, pp. 315–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, supplement 1, pp. S1–S266, 2002. View at Google Scholar
  17. R. Xu, L. Zhang, P. Zhang et al., “Gender-specific reference value of urine albumin-creatinine ratio in healthy Chinese adults: results of the Beijing CKD survey,” Clinica Chimica Acta, vol. 398, no. 1-2, pp. 125–129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. I. Weitz, J. Byrne, G. P. Clagett et al., “Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review,” Circulation, vol. 94, pp. 3026–3049, 1996. View at Publisher · View at Google Scholar
  19. P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, no. 18, pp. 1837–1847, 1998. View at Google Scholar · View at Scopus
  20. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Crepaldi and S. Maggi, “The metabolic syndrome: a historical context,” Diabetes Voice, vol. 51, pp. 8–10, 2006. View at Google Scholar
  22. R. G. Nelson, P. H. Bennett, G. J. Beck et al., “Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus: diabetic renal disease study group,” The New England Journal of Medicine, vol. 335, pp. 1636–1642, 1996. View at Publisher · View at Google Scholar
  23. L. L. Humphrey, D. J. Ballard, P. P. Frohnert, C.-P. Chu, M. O'Fallon, and P. J. Palumbo, “Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota,” Annals of Internal Medicine, vol. 111, no. 10, pp. 788–796, 1989. View at Google Scholar · View at Scopus
  24. L. Palaniappan, M. Carnethon, and S. P. Fortmann, “Association between microalbuminuria and the metabolic syndrome: NHANES III,” American Journal of Hypertension, vol. 16, no. 11, pp. 952–958, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. A. K. Singh and J. A. Kari, “Metabolic syndrome and chronic kidney disease,” Current Opinion in Nephrology and Hypertension, vol. 22, no. 2, pp. 198–203, 2013. View at Publisher · View at Google Scholar
  26. C. S. Fox, M. G. Larson, E. P. Leip, B. Culleton, P. W. F. Wilson, and D. Levy, “Predictors of new-onset kidney disease in a community-based population,” Journal of the American Medical Association, vol. 291, no. 7, pp. 844–850, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. O. Samuelsson, P.-O. Attman, C. Knight-Gibson et al., “Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency,” Journal of the American Society of Nephrology, vol. 9, no. 8, pp. 1482–1488, 1998. View at Google Scholar · View at Scopus
  28. I. Codreanu, N. Perico, and G. Remuzzi, “Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection?” Journal of the American Society of Nephrology, vol. 16, supplement 1, pp. S34–S38, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. E. Molitch, R. A. DeFronzo, M. J. Franz et al., “Diabetic nephropathy,” Diabetes Care, vol. 26, supplement 1, pp. S94–S98, 2003. View at Google Scholar · View at Scopus